<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04029389</url>
  </required_header>
  <id_info>
    <org_study_id>GaziosmanpasaTREH8</org_study_id>
    <nct_id>NCT04029389</nct_id>
  </id_info>
  <brief_title>Ultrasound-Guided Tibial Nerve Block vs. Local Corticosteroid Injection in Recalcitrant Plantar Fasciitis Treatment</brief_title>
  <official_title>Ultrasound-Guided Tibial Nerve Block vs. Local Corticosteroid Injection: A Randomized Controlled Study for Recalcitrant Plantar Fasciitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gaziosmanpasa Taksim Research and Education Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gaziosmanpasa Taksim Research and Education Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized controlled study to search for the efficiency of tibial nerve block vs local
      corticosteroid injection of the plantar fascia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Three groups will be formed. After ESWT therapy, if the patients still suffer from pain (&gt; 5
      points, visual analog scale(0-10points), participants will be included in the study. One
      group will receive conversational therapy. Second group will be treated with local
      corticosteroid injection. And third group will be treated with tibial nerve block.
      Before-treatment, after one week, after six weeks and after 3 months evaluation of the
      patients will be performed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS-Pain</measure>
    <time_frame>Three months</time_frame>
    <description>A scale on 0-10 points. 0 points indicate no pain, and 10 points show worst pain ever</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">78</enrollment>
  <condition>Plantar Fascitis</condition>
  <condition>Tibial Nerve</condition>
  <condition>Injections</condition>
  <condition>Ultrasonography</condition>
  <arm_group>
    <arm_group_label>Recalcitrant Plantar Fasciitis/Conservational</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After ESWT therapy patients suffer from extreme pain will recieve only conservational therapy (26 patients)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Recalcitrant Plantar Fasciitis/Local</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After ESWT therapy patients suffer from extreme pain will receive local steroid injections</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Recalcitrant Plantar Fasciitis/Tibial nerve</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After ESWT therapy patients suffer from extreme pain will receive tibial nerve block</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Injection</intervention_name>
    <description>Local corticosteroid injection</description>
    <arm_group_label>Recalcitrant Plantar Fasciitis/Local</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tibial nerve block</intervention_name>
    <description>Tibial nerve block</description>
    <arm_group_label>Recalcitrant Plantar Fasciitis/Tibial nerve</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conservational therapy</intervention_name>
    <description>Only exercise and foot insoles</description>
    <arm_group_label>Recalcitrant Plantar Fasciitis/Conservational</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Recalcitrant plantar Fasciitis

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ebru Yalçınkaya</last_name>
    <role>Study Director</role>
    <affiliation>Gaziosmanpasa Taksim Training and Research Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mehmet Akif A Guler, M.D.</last_name>
    <phone>+905054930098</phone>
    <email>makifguler89@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zeynel Karakullukcuoglu, M.D.</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gaziosmanpasa Taksim Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <state>İ̇stanbul</state>
        <zip>34255</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mehmet Akif Guler</last_name>
      <phone>5054930098</phone>
      <email>makifguler89@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 20, 2019</study_first_submitted>
  <study_first_submitted_qc>July 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2019</study_first_posted>
  <last_update_submitted>July 31, 2019</last_update_submitted>
  <last_update_submitted_qc>July 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gaziosmanpasa Taksim Research and Education Hospital</investigator_affiliation>
    <investigator_full_name>Mehmet Akif GÜLER</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Plantar Fascitis</keyword>
  <keyword>Tibial Nerve</keyword>
  <keyword>Injections</keyword>
  <keyword>Ultrasonography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fasciitis</mesh_term>
    <mesh_term>Fasciitis, Plantar</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

